Minimizing the Immune Response: Overcoming the Hurdles to Successful AAV Gene Therapies

Time: 11:00 am
day: Immunogenicity Discussion Day


  • Understanding the complex mixture of innate, humoral and cellular immunogenicity concerns with AAV
  • Exploring the state of play between ‘one and done’ and redosing strategies
  • Combatting high dose AAV toxicities with new strategies